Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,315 | 211 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $695.49 | 39 | $0 (2024) |
| Novo Nordisk Inc | $534.44 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $419.88 | 16 | $0 (2024) |
| PFIZER INC. | $332.68 | 22 | $0 (2024) |
| Amgen Inc. | $313.10 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $233.08 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $212.92 | 6 | $0 (2023) |
| Lilly USA, LLC | $177.54 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $161.59 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $99.68 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,371 | 76 | Novo Nordisk Inc ($190.40) |
| 2023 | $2,455 | 104 | AbbVie Inc. ($356.50) |
| 2022 | $476.08 | 30 | ABBVIE INC. ($158.27) |
| 2021 | $12.82 | 1 | Aveo Pharmaceuticals, Inc. ($12.82) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Sandoz Inc. | — | Food and Beverage | In-kind items and services | $32.80 | General |
| 11/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PAIN | ||||||
| 11/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $18.11 | General |
| Category: Endocrinology | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: UROLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/23/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: PAIN | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.47 | General |
| Category: PAIN | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 608 | 1,803 | $226,396 | $56,415 |
| 2022 | 6 | 310 | 325 | $79,513 | $15,348 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 437 | $89,148 | $19,235 | 21.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 960 | $42,240 | $17,778 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 161 | 161 | $51,359 | $8,404 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $14,265 | $4,740 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 53 | $7,314 | $2,258 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 25 | $6,850 | $1,704 | 24.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,840 | $752.66 | 19.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 20 | 21 | $6,069 | $719.36 | 11.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 38 | $2,622 | $386.26 | 14.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 21 | $1,239 | $200.64 | 16.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 14 | $1,274 | $181.31 | 14.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 16 | $176.00 | $54.56 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 150 | $30,600 | $6,455 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $35,090 | $5,133 | 14.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 23 | 23 | $4,209 | $1,616 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,804 | $1,206 | 31.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 17 | 17 | $4,913 | $581.23 | 11.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $897.00 | $356.46 | 39.7% |
About Dr. Brianna Bingham, DO
Dr. Brianna Bingham, DO is a Internal Medicine healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2019. The National Provider Identifier (NPI) number assigned to this provider is 1396305389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brianna Bingham, DO has received a total of $4,315 in payments from pharmaceutical and medical device companies, with $1,371 received in 2024. These payments were reported across 211 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,315).
As a Medicare-enrolled provider, Bingham has provided services to 918 Medicare beneficiaries, totaling 2,128 services with total Medicare billing of $71,762. Data is available for 2 years (2022–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Kansas City, KS
- Active Since 06/20/2019
- Last Updated 01/08/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396305389
Products in Payments
- BREZTRI (Drug) $331.87
- VRAYLAR (Drug) $284.25
- Wegovy (Drug) $244.83
- Veozah (Drug) $233.08
- NURTEC ODT (Drug) $203.91
- EVENITY (Biological) $170.42
- UBRELVY (Drug) $170.38
- ELIQUIS (Drug) $128.77
- Rybelsus (Drug) $127.52
- Nubeqa (Drug) $123.28
- AREXVY (Drug) $117.28
- MOUNJARO (Drug) $110.69
- Ozempic (Drug) $110.30
- Otezla (Drug) $107.02
- Kerendia (Drug) $89.64
- Cologuard Collection Kit (Device) $89.02
- XARELTO (Drug) $87.07
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $78.10
- QULIPTA (Drug) $74.81
- Tymlos (Drug) $67.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kansas City
James O'keefe, Md, MD
Internal Medicine — Payments: $834,178
Shadi Hamdeh, Md, MD
Internal Medicine — Payments: $623,244
Dr. Patrick Moriarty, M.d, M.D
Internal Medicine — Payments: $618,967
Gerald Mancuso, M.d, M.D
Internal Medicine — Payments: $615,894
Dr. Ryan Taylor, M.d, M.D
Internal Medicine — Payments: $512,094
Sanjaya Gupta, Md, MD
Internal Medicine — Payments: $325,155